Brief: Bone Therapeutics Appoints Anthony Ting As Chief Scientific Officer
March 30 (Reuters) - BONE THERAPEUTICS SA BOTHE.BR :
* BONE THERAPEUTICS APPOINTS INDUSTRY CELL THERAPY EXPERT,
ANTHONY
TING, PHD AS CHIEF SCIENTIFIC OFFICER
Source text for Eikon: ID:nGNE2bQJW0
Further company coverage: BOTHE.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Biosenic SA
See all newsBrief: Biosenic Says Enterprise Court Of Nivelles Approves Co's Restructuring Plan
Brief: Biosenic Anticipates Having Sufficient Cash To Carry Out Its Business Objectives Until Q3 2024
Brief: BioSenic Patent Granted In Canada For Broader Protection Of ATO Therapeutic Platform
Brief: Biosenic Files For Additional Patent Protection For Osteoarthritis Drug
Brief: BioSenic Signs New Binding Term Sheet With Phebra PTY Ltd